H35.053
Retinal neovascularization, unspecified, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinal neovascularization refers to the abnormal growth of new blood vessels within the retina, the light-sensitive tissue at the back of the eye. When these vessels develop excessively, they can lead to serious vision problems or even vision loss. The term 'bilateral' indicates that this condition occurs in both eyes. This condition is often identified using the ICD-10 code H35.053, which specifies retinal neovascularization in both eyes without a specific cause.
Causes & Symptoms
Clinical Causes: Diabetic retinopathy: a complication of diabetes affecting the blood vessels of the retina. Retinal vein occlusion: blockage of small veins in the retina leading to decreased blood flow. Age-related macular degeneration: a disease that causes deterioration of the central part of the retina. Oxygen deprivation (hypoxia): reduced oxygen supply to the retina can stimulate abnormal blood vessel growth. Other retinal vascular disorders: various conditions affecting the blood vessels within the eye.
Key Symptoms: Blurred vision or visual distortions Floating spots or flickering lights Sudden vision loss in some cases Visual field loss or blind spots Color perception changes
Diagnostic & Treatment
Diagnosis Path: Diagnosing retinal neovascularization involves comprehensive eye examinations performed by an eye care professional. Key diagnostic methods include: - Fundoscopy: visualization of the retina through an ophthalmoscope. - Fluorescein angiography: a test involving dye injection to observe blood flow in retinal vessels. - Optical coherence tomography (OCT): imaging technique providing cross-sectional views of the retina. These assessments help confirm the presence of abnormal new blood vessels and determine their extent and impact on the retina.
Treatment Protocols: Management of retinal neovascularization aims to control abnormal blood vessel growth, prevent complications, and preserve vision. Typical treatment options include: - Laser photocoagulation: laser therapy to seal off leaking or abnormal vessels. - Anti-vascular endothelial growth factor (anti-VEGF) injections: medications administered directly into the eye to inhibit new vessel formation. - Corticosteroids: used in some cases to reduce inflammation. - Addressing underlying causes: such as managing diabetes or hypertension. Decisions about treatment are individualized based on the severity and specific circumstances of each case.
Clinical Advice & FAQs
Billing Guidance
Is H35.053 a billable ICD-10 code?
Yes, H35.053 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.053?
Clinical documentation must specify the nature of Retinal neovascularization, unspecified, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
